Allphase Pharma Consulting, LLC
A Professional Service Provider for the Pharma Industry
As many in the field have said before, what we really need are antifungals with a truly novel MoA, not minor changes to well-established classes.[1] There is a shortage of new antifungals for invasive disease. Small improvements in PK will hardly move the field forward or excite investors to engage. Our current Continue reading The Antifungal Landscape – 2
As noticed by many other colleagues, ICAAC 2015 was a shadow of its former self. Few participants overall, fewer posters, and even fewer exhibitors. Reviewing the posters, there were relatively few from industry, most came from university or small research labs. In a way, ICAAC 2015 was a true reflection of Continue reading Two New Antifungals Presented at ICAAC San Diego